{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:53:51Z","timestamp":1780995231898,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suqian Sci\uff06Tech Program,Grant","award":["KY202205"],"award-info":[{"award-number":["KY202205"]}]},{"name":"Suqian Sci\uff06Tech Program,Grant","award":["KY202205"],"award-info":[{"award-number":["KY202205"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82204866"],"award-info":[{"award-number":["No. 82204866"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Natural Science Foundation of Jiangsu Province","award":["BK20231163"],"award-info":[{"award-number":["BK20231163"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05929-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:16:10Z","timestamp":1751393770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hypoxia-induced HIF-1\u03b1\/VASN promotes bladder cancer progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian-jin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-sheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5929_CR1","first-page":"e076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in diagnosis and treatment of bladder cancer. BMJ (Clinical Res. ed). 384, e076743 (2024).","journal-title":"BMJ (Clinical Res. ed)"},{"issue":"4","key":"5929_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","volume":"22","author":"TW Flaig","year":"2024","unstructured":"Flaig, T. W. et al. NCCN Guidelines\u00ae insights: bladder cancer, version 3.2024. J. Natl. Compr. Canc Netw. 22 (4), 216\u2013225 (2024).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"4","key":"5929_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein, J. M. et al. Diagnosis and treatment of Non-Muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J. Urol. 211 (4), 533\u2013538 (2024).","journal-title":"J. Urol."},{"key":"5929_CR4","doi-asserted-by":"publisher","first-page":"105152","DOI":"10.1016\/j.ebiom.2024.105152","volume":"104","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer. EBioMedicine 104, 105152 (2024).","journal-title":"EBioMedicine"},{"issue":"5","key":"5929_CR5","doi-asserted-by":"publisher","first-page":"e18101","DOI":"10.1111\/jcmm.18101","volume":"28","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Immunotherapeutic prospects and progress in bladder cancer. J. Cell. Mol. Med. 28 (5), e18101 (2024).","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"5929_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12967-024-04860-1","volume":"22","author":"H Yuan","year":"2024","unstructured":"Yuan, H. et al. Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. J. Transl Med. 22 (1), 48 (2024).","journal-title":"J. Transl Med."},{"issue":"12","key":"5929_CR7","doi-asserted-by":"publisher","first-page":"e23260","DOI":"10.1096\/fj.202301095R","volume":"37","author":"H Chen","year":"2023","unstructured":"Chen, H., Ma, L., Yang, W., Li, Y. & Ji, Z. POLR3G promotes EMT via PI3K\/AKT signaling pathway in bladder cancer. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 37 (12), e23260 (2023).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"key":"5929_CR8","doi-asserted-by":"publisher","first-page":"110971","DOI":"10.1016\/j.cellsig.2023.110971","volume":"113","author":"CH Liu","year":"2024","unstructured":"Liu, C. H. et al. METTL3 regulates the proliferation, metastasis and EMT progression of bladder cancer through P3H4. Cell. Signal. 113, 110971 (2024).","journal-title":"Cell. Signal."},{"issue":"1661","key":"5929_CR9","doi-asserted-by":"publisher","first-page":"20140042","DOI":"10.1098\/rstb.2014.0042","volume":"370","author":"RT Bryan","year":"2015","unstructured":"Bryan, R. T. Cell adhesion and urothelial bladder cancer: the role of Cadherin switching and related phenomena. Philos. Trans. R Soc. Lond. B Biol. Sci. 370 (1661), 20140042 (2015).","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"issue":"1","key":"5929_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","volume":"24","author":"R Cao","year":"2020","unstructured":"Cao, R. et al. An EMT-related gene signature for the prognosis of human bladder cancer. J. Cell. Mol. Med. 24 (1), 605\u2013617 (2020).","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"5929_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12967-022-03508-2","volume":"20","author":"Q Song","year":"2022","unstructured":"Song, Q. et al. Bladder cancer-derived Exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. J. Transl Med. 20 (1), 308 (2022).","journal-title":"J. Transl Med."},{"issue":"13","key":"5929_CR12","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.7150\/ijbs.69373","volume":"18","author":"L Ren","year":"2022","unstructured":"Ren, L. et al. Nitroxoline suppresses metastasis in bladder cancer via EGR1\/circNDRG1\/miR-520\u00a0h\/smad7\/EMT signaling pathway. Int. J. Biol. Sci. 18 (13), 5207\u20135220 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"5929_CR13","doi-asserted-by":"publisher","first-page":"216023","DOI":"10.1016\/j.canlet.2022.216023","volume":"554","author":"X Meng","year":"2023","unstructured":"Meng, X. et al. CircPTK2\/PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Lett. 554, 216023 (2023).","journal-title":"Cancer Lett."},{"issue":"3","key":"5929_CR14","doi-asserted-by":"publisher","first-page":"300060521992900","DOI":"10.1177\/0300060521992900","volume":"49","author":"H Geng","year":"2021","unstructured":"Geng, H. et al. Diallyl trisulfide inhibited tobacco smoke-mediated bladder EMT and cancer stem cell marker expression via the NF-\u03baB pathway in vivo. J. Int. Med. Res. 49 (3), 300060521992900 (2021).","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"5929_CR15","doi-asserted-by":"publisher","first-page":"e14272","DOI":"10.1016\/j.heliyon.2023.e14272","volume":"9","author":"W Hu","year":"2023","unstructured":"Hu, W. et al. Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages. Heliyon 9 (3), e14272 (2023).","journal-title":"Heliyon"},{"issue":"7","key":"5929_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/1566524023666230720163448","volume":"24","author":"J Chai","year":"2024","unstructured":"Chai, J., Yin, S., Feng, W., Zhang, T. & Ke, C. The role of Hypoxia-inducible Factor-1 in bladder Cancer. Curr. Mol. Med. 24 (7), 827\u2013834 (2024).","journal-title":"Curr. Mol. Med."},{"issue":"7","key":"5929_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cac2.12158","volume":"41","author":"JZ Wang","year":"2021","unstructured":"Wang, J. Z. et al. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in Glycolysis and tumorigenesis of bladder cancer. Cancer Commun. (Lond). 41 (7), 560\u2013575 (2021).","journal-title":"Cancer Commun. (Lond)"},{"issue":"10","key":"5929_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41419-023-06189-x","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. CDCA8 promotes bladder cancer survival by stabilizing HIF1\u03b1 expression under hypoxia. Cell Death Dis. 14 (10), 658 (2023).","journal-title":"Cell Death Dis."},{"issue":"1","key":"5929_CR19","doi-asserted-by":"publisher","first-page":"2273282","DOI":"10.1080\/09513590.2023.2273282","volume":"39","author":"A La Marca","year":"2023","unstructured":"La Marca, A., De Carlini, S. & Liuzzi, F. Vasorin: a new molecule in human reproduction? Gynecol. Endocrinol. 39 (1), 2273282 (2023).","journal-title":"Gynecol. Endocrinol."},{"key":"5929_CR20","doi-asserted-by":"publisher","first-page":"110809","DOI":"10.1016\/j.cellsig.2023.110809","volume":"110","author":"F Wan","year":"2023","unstructured":"Wan, F. et al. Vasorin promotes proliferation and migration via STAT3 signaling and acts as a promising therapeutic target of hepatocellular carcinoma. Cell. Signal. 110, 110809 (2023).","journal-title":"Cell. Signal."},{"issue":"1","key":"5929_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s12967-024-05473-4","volume":"22","author":"D Kang","year":"2024","unstructured":"Kang, D. et al. Vasorin (VASN) overexpression promotes pulmonary metastasis and resistance to adjuvant chemotherapy in patients with locally advanced rectal cancer. J. Transl Med. 22 (1), 742 (2024).","journal-title":"J. Transl Med."},{"issue":"12","key":"5929_CR22","first-page":"6589","volume":"24","author":"FL Cui","year":"2020","unstructured":"Cui, F. L., Mahmud, A. N., Xu, Z. P., Wang, Z. Y. & Hu, J. P. VASN promotes proliferation of prostate cancer through the YAP\/TAZ axis. Eur. Rev. Med. Pharmacol. Sci. 24 (12), 6589\u20136596 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"5929_CR23","doi-asserted-by":"publisher","first-page":"e22688","DOI":"10.1096\/fj.202201181R","volume":"37","author":"W Liang","year":"2023","unstructured":"Liang, W. et al. VASN promotes colorectal cancer progression by activating the YAP\/TAZ and AKT signaling pathways via YAP. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 37 (1), e22688 (2023).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"issue":"6","key":"5929_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.clon.2021.03.001","volume":"33","author":"T Lodhi","year":"2021","unstructured":"Lodhi, T., Song, Y. P., West, C., Hoskin, P. & Choudhury, A. Hypoxia and its modification in bladder cancer: current and future perspectives. Clin. Oncol. (R Coll. Radiol). 33 (6), 376\u2013390 (2021).","journal-title":"Clin. Oncol. (R Coll. Radiol)"},{"key":"5929_CR25","doi-asserted-by":"publisher","first-page":"216792","DOI":"10.1016\/j.canlet.2024.216792","volume":"588","author":"C Castillo","year":"2024","unstructured":"Castillo, C. et al. Hypoxia effects on glioblastoma progression through YAP\/TAZ pathway regulation. Cancer Lett. 588, 216792 (2024).","journal-title":"Cancer Lett."},{"issue":"4","key":"5929_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.7150\/ijbs.39414","volume":"16","author":"L Wei","year":"2020","unstructured":"Wei, L. et al. Integrin \u03b23 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the pten\/akt\/mtor and ERK1\/2 pathways. Int. J. Biol. Sci. 16 (4), 644\u2013654 (2020).","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"5929_CR27","doi-asserted-by":"publisher","first-page":"e22840","DOI":"10.1096\/fj.202201247R","volume":"37","author":"X Li","year":"2023","unstructured":"Li, X. et al. P4HA2-mediated HIF-1\u03b1 stabilization promotes erdafitinib-resistance in FGFR3-alteration bladder cancer. FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology. 37 (4), e22840 (2023).","journal-title":"FASEB Journal: Official Publication Federation Am. Soc. Experimental Biology"},{"key":"5929_CR28","doi-asserted-by":"publisher","first-page":"859707","DOI":"10.3389\/fonc.2022.859707","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Li, X., Ren, S. & Zhang, W. CNN1 represses bladder Cancer progression and metabolic reprogramming by modulating HIF-1\u03b1 signaling pathway. Front. Oncol. 12, 859707 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"5929_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing, X. et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. Cancer. 18 (1), 157 (2019).","journal-title":"Mol. Cancer"},{"issue":"8","key":"5929_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","volume":"16","author":"C Alifrangis","year":"2019","unstructured":"Alifrangis, C., McGovern, U., Freeman, A., Powles, T. & Linch, M. Molecular and histopathology directed therapy for advanced bladder cancer. Nat. Rev. Urol. 16 (8), 465\u2013483 (2019).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"5929_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1186\/s12885-024-13083-y","volume":"24","author":"DN Wu","year":"2024","unstructured":"Wu, D. N. et al. VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinoma. BMC Cancer. 24 (1), 1327 (2024).","journal-title":"BMC Cancer"},{"issue":"4","key":"5929_CR32","first-page":"1563","volume":"26","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. VASN promotes proliferation of laryngeal cancer cells via YAP\/TAZ. J. Buon. 26 (4), 1563\u20131570 (2021).","journal-title":"J. Buon"},{"issue":"1","key":"5929_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tranon.2019.09.001","volume":"13","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. Vasorin\/ATIA promotes cigarette Smoke-Induced transformation of human bronchial epithelial cells by suppressing Autophagy-Mediated apoptosis. Transl Oncol. 13 (1), 32\u201341 (2020).","journal-title":"Transl Oncol."},{"issue":"10","key":"5929_CR34","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.1007\/s11033-022-07780-9","volume":"49","author":"X Guo","year":"2022","unstructured":"Guo, X. et al. Vasorin contributes to lung injury via FABP4-mediated inflammation. Mol. Biol. Rep. 49 (10), 9335\u20139344 (2022).","journal-title":"Mol. Biol. Rep."},{"issue":"8","key":"5929_CR35","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/cas.14103","volume":"110","author":"W Liang","year":"2019","unstructured":"Liang, W. et al. Vasorin stimulates malignant progression and angiogenesis in glioma. Cancer Sci. 110 (8), 2558\u20132572 (2019).","journal-title":"Cancer Sci."},{"key":"5929_CR36","doi-asserted-by":"crossref","unstructured":"Wicks, E. E. & Semenza, G. L. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin. Invest 132(11). (2022).","DOI":"10.1172\/JCI159839"},{"issue":"49","key":"5929_CR37","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1038\/s41388-023-02869-2","volume":"42","author":"P Fan","year":"2023","unstructured":"Fan, P. et al. Alleviating hypoxia to improve cancer immunotherapy. Oncogene 42 (49), 3591\u20133604 (2023).","journal-title":"Oncogene"},{"issue":"12","key":"5929_CR38","doi-asserted-by":"publisher","first-page":"23169","DOI":"10.1002\/jcp.28883","volume":"234","author":"WL Lv","year":"2019","unstructured":"Lv, W. L., Liu, Q., An, J. H. & Song, X. Y. Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells. J. Cell. Physiol. 234 (12), 23169\u201323175 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"5929_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.stem.2017.10.005","volume":"22","author":"J Man","year":"2018","unstructured":"Man, J. et al. Hypoxic induction of Vasorin regulates Notch1 turnover to maintain glioma Stem-like cells. Cell. Stem Cell. 22 (1), 104\u2013118e106 (2018).","journal-title":"Cell. Stem Cell."},{"issue":"7","key":"5929_CR40","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/jcmm.17229","volume":"26","author":"JA Choi","year":"2022","unstructured":"Choi, J. A. et al. Role of vasorin, an anti-apoptotic, anti-TGF-\u03b2 and hypoxia-induced glycoprotein in the trabecular meshwork cells and glaucoma. J. Cell. Mol. Med. 26 (7), 2063\u20132075 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"5929_CR41","doi-asserted-by":"crossref","unstructured":"Diao, H., Li, J., Fan, J., Fan, Y. & Chen, W. WCN23-0909 Vasorin regulates the HIF-1\u0251 \/MAPK signaling pathway to improve AKI. Kidney Int. Reports (2023).","DOI":"10.1016\/j.ekir.2023.02.080"},{"issue":"1","key":"5929_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12935-024-03570-4","volume":"24","author":"Y Yan","year":"2024","unstructured":"Yan, Y. et al. IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer. Cancer Cell. Int. 24 (1), 386 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"7","key":"5929_CR43","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/mc.23725","volume":"63","author":"L Qing","year":"2024","unstructured":"Qing, L. et al. Hypoxia-mediated Attenuation of EGLN2 Inhibition of the NF-\u03baB signaling pathway leads to the formation of a loop between HIF-1\u03b1 and MUC1-C promoting chemoresistance in bladder cancer. Mol. Carcinog. 63 (7), 1303\u20131318 (2024).","journal-title":"Mol. Carcinog."},{"issue":"1","key":"5929_CR44","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1038\/s41598-017-05512-9","volume":"7","author":"MC Chen","year":"2017","unstructured":"Chen, M. C., Hsu, W. L., Chang, W. L. & Chou, T. C. Antiangiogenic activity of phthalides-enriched Angelica sinensis extract by suppressing WSB-1\/pVHL\/HIF-1\u03b1\/VEGF signaling in bladder cancer. Sci. Rep. 7 (1), 5376 (2017).","journal-title":"Sci. Rep."},{"issue":"6","key":"5929_CR45","doi-asserted-by":"publisher","first-page":"C1485","DOI":"10.1152\/ajpcell.00270.2023","volume":"325","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Itga8-Cre-mediated deletion of YAP and TAZ impairs bladder contractility with minimal inflammation and chondrogenic differentiation. Am. J. Physiol. Cell. Physiol. 325 (6), C1485\u2013c1501 (2023).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"1","key":"5929_CR46","first-page":"9","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo, S., Panciera, T., Contessotto, P. & Cordenonsi, M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat. Cancer. 4 (1), 9\u201326 (2023).","journal-title":"Nat. Cancer"},{"issue":"5","key":"5929_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","volume":"5","author":"CDK Nguyen","year":"2019","unstructured":"Nguyen, C. D. K. & Yi, C. YAP\/TAZ signaling and resistance to Cancer therapy. Trends Cancer. 5 (5), 283\u2013296 (2019).","journal-title":"Trends Cancer"},{"issue":"9","key":"5929_CR48","doi-asserted-by":"publisher","first-page":"15173","DOI":"10.3390\/ijms150915173","volume":"15","author":"Y Gao","year":"2014","unstructured":"Gao, Y. et al. Curcumin promotes KLF5 proteasome degradation through downregulating YAP\/TAZ in bladder cancer cells. Int. J. Mol. Sci. 15 (9), 15173\u201315187 (2014).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"5929_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12935-023-02997-5","volume":"23","author":"F Zou","year":"2023","unstructured":"Zou, F. et al. SQLE knockdown inhibits bladder cancer progression by regulating the PTEN\/AKT\/GSK3\u03b2 signaling pathway through P53. Cancer Cell. Int. 23 (1), 221 (2023).","journal-title":"Cancer Cell. Int."},{"issue":"2","key":"5929_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ddr.21751","volume":"82","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Bergenin inhibits bladder cancer progression via activating the PPAR\u03b3\/PTEN\/Akt signal pathway. Drug Dev. Res. 82 (2), 278\u2013286 (2021).","journal-title":"Drug Dev. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05929-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05929-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05929-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:12:17Z","timestamp":1751397137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05929-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5929"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05929-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study strictly adhered to the ethical principles outlined in the Declaration of Helsinki. The research protocol was reviewed and approved by the Medical Ethics Committee of Suqian First People\u2019s Hospital (Ethics Approval No.: 2023-SL-0054). Prior to study implementation, all participants provided written informed consent after being fully informed of the research objectives, procedures, and potential risks.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical consideration"}}],"article-number":"21635"}}